CVE-2018-10597IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Mate…
Updated under an hour ago ()
Does this affect you?
It affects ICS-CERT IntelliVue Patient Monitors, Avalon Fetal/Maternal Monitors and 18 other products. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.40%, higher than 34% of scored CVEs.
Do this next
Free account, 1 product
IntelliVue Patient Monitors MP Series (including MP2/X2/MP30/MP50/MP70/NP90/MX700/800) Rev B-M, IntelliVue Patient Monitors MX (MX400-550) Rev J-M and (X3/MX100 for Rev M only), and Avalon Fetal/Maternal Monitors FM20/FM30/FM40/FM50 with software Revisions F.0, G.0 and J.3 have a vulnerability that allows an unauthenticated attacker to access memory ("write-what-where") from an attacker-chosen device address within the same subnet.
- CVSS
- 8.3 HIGH (v3.1, NVD)CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- CWE-287
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.40% (percentile 34)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Sep 16, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.